Research discovery

Find the original research

Live search across PubMed, the U.S. National Library of Medicine's citation database, and ClinicalTrials.gov. We show what each record is and link you to it; we don't summarise findings or rank studies by what they conclude.

Published studies · PubMed Clinical trials · ClinicalTrials.gov

Find the original research

CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users (opens ClinicalTrials.gov)

Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults (opens ClinicalTrials.gov)

Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes (opens ClinicalTrials.gov)

A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial) (opens ClinicalTrials.gov)

Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese (opens ClinicalTrials.gov)

Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity (opens ClinicalTrials.gov)

Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment (opens ClinicalTrials.gov)

Safety and Effectiveness of Tirzepatide in Patients With Obesity at Hospital de Clínicas, Paraguay (opens ClinicalTrials.gov)

A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (opens ClinicalTrials.gov)

Tirzepatide to Slow Biological Aging (opens ClinicalTrials.gov)

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity (opens ClinicalTrials.gov)

DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies (opens ClinicalTrials.gov)

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1) (opens ClinicalTrials.gov)

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes (opens ClinicalTrials.gov)

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide (opens ClinicalTrials.gov)

Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors (opens ClinicalTrials.gov)

Tirzepatide (Spartina) in Obese Kidney Transplant Recipients (opens ClinicalTrials.gov)

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight (opens ClinicalTrials.gov)

Tirzepatide Weight Loss for MRD+ Early Breast Cancer (opens ClinicalTrials.gov)

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder (opens ClinicalTrials.gov)